GlaxoSmithKline says it is co-operating with Chinese authorities in the inquiry
Chinese authorities looking into alleged bribery by GlaxoSmithKline have banned the UK drugmaker's British head of finance from leaving China.
The travel ban was imposed on Steve Nechelput at the end of June, said a company spokesperson.
On Monday, police in China said GSK had transferred 3bn yuan ($489m; £321m) to travel agencies and consultancies to facilitate bribes to doctors.
GSk has said it is deeply "concerned and disappointed" by the allegations.
Chinese authorities have taken into custody four Chinese executives at GSK in connection with the allegations. The company said Mr Nechelput had not been questioned or detained by police.
GSK's general manager for China, Mark Reilly, left the country on 5 July for Britain.
Chinese authorities have accused GSK of using travel agencies to bribe government officials, doctors and hospitals in order to boost sales and prices of their drugs.
On Monday, Gao Feng, head of the economic crimes investigation, said similar transfers had been made by other pharmaceutical multinationals. He did not name any other foreign companies.
Source: BBC News - Business http://www.bbc.co.uk/news/business-23352844#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa
